Back to User profile » Dr Andreas Kuznik
Papers published by Dr Andreas Kuznik:
Incremental Costs Associated with Length of Hospitalization Due to Viral Pneumonia: Impact of Intensive Care and Economic Implications of Reducing the Length of Stay in the Era of COVID-19
Wu N, Kuznik A, Wang D, Moretz C, Xi A, Kumar S, Hamilton L
ClinicoEconomics and Outcomes Research 2020, 12:723-731
Published Date: 2 December 2020
Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient
Fournier M, Chen C, Kuznik A, Proudfoot C, Mallya UG, Michaud K
ClinicoEconomics and Outcomes Research 2019, 11:117-128
Published Date: 5 February 2019
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Corrigendum]
Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C
ClinicoEconomics and Outcomes Research 2019, 11:83-85
Published Date: 14 January 2019
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies
Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C
ClinicoEconomics and Outcomes Research 2018, 10:805-819
Published Date: 16 November 2018